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Abstract
The hypothalamus is a brain structure at the center of a variety of regulatory functions that
have been explored by scientists and clinicians for almost a century. Among these functions,
metabolic regulation and the control of appetitive behaviors have been fields of intensive research.
Some of the major neural substrates involved in the hypothalamic control of feeding and the
regulation of metabolic state include neuronal populations that express the neuropeptides alphamelanocyte stimulating hormone (αMSH), melanin-concentrating hormone (MCH) and
hypocretin/orexin (H/O). αMSH has been characterized in part as an anorexigenic peptide, while
MCH and H/O have been characterized as having orexigenic effects. The functionally opposing
nature of these neuropeptides has prompted researchers to investigate the effects that αMSH might
have in modulating H/O and MCH actions, which has uncovered structural evidence of putative
appositions between axonal fibers from hypothalamic cells expressing αMSH and cell bodies, or
somata, of other hypothalamic cells expressing either H/O or MCH. However, these groups did
not report their findings within a standardized spatial framework, nor did they provide detailed cospatial distributions – for the regions of possible synaptic interactions – for these neuropeptides.
In the present study, immunohistochemical staining and rigorous atlas-based mapping were used
to pinpoint the distributions of αMSH-, MCH- and H/O-immunoreactive somata and fibers
throughout the anterior, and tuberal hypothalamus in order to determine regions with a high
likelihood of local interactions or co-spatial expression. Additionally, at a finer scale, these
methods were employed to report with high-spatial resolution the distributions of possible synaptic
interactions of αMSH-ir fibers with either MCH- or H/O-ir somata. Collectively, these data will
allow for more quantitative hypothesis-testing to determine whether there is a clear pattern or
organization of the distributions of these neuropeptides and their structural interactions.
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Chapter I: Introduction
The location and organization of the hypothalamus makes it an ideal brain structure for the
integration of information received by the central nervous system and the periphery (Simerly 2015,
Schwartz et al 2000). Therefore, it is also an ideal structure for mediating behaviors and regulatory
functions that are essential for survival. These include feeding, wakefulness, fluid balance,
thermoregulation, sexual behaviors, reproduction, as well as the stress response and aggression
(Saper and Lowell 2014). In order for the hypothalamus to perform these functions, it has neurons
that are specialized to interact with signals coming from the periphery, which are in the form of
hormones or levels of circulating molecules which directly are measure of some aspect of internal
state (i.e., glucose, lipids, amino acids, osmolytes, temperature) (Routh et al 2014, Saper and
Lowell 2014, Schwartz et al 2000, Siemens and Kamm 2018). Additionally, the hypothalamus
receives inputs from regions that have processed sensory information and is believed to
contextualize the signals being received from the periphery in order to produce adequate
physiological responses to the information it is integrating (Dampney 2011; Saper and Lowell
2014).
Due to the integrative role of the hypothalamus in these essential responses, there has been
strong research interest in defining its afferent and efferent connections. These efforts have
demonstrated that hypothalamic regions receive hindbrain-originating afferents which provide
direct sensory information, as in the case of thermoregulation, and also receive afferents from
limbic regions such as the amygdala, cingulate cortex, and hippocampus; which can add salience
and pathway-specific importance to the signals being processed by the hypothalamus in order to
produce emotional responses based on physiological cues (Saper and Lowell 2014). These
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incoming signals are processed and then ultimately result in the generation of efferent signals that
can elicit either hormonal or vagal responses through the pituitary gland or through hindbrain
projections.
However, information coming to and from the hypothalamus through these connections is
not the complete story. Intrahypothalamic signaling is essential for processing the information
coming to the hypothalamus and generating the appropriate output. Despite the critical importance
of such signaling, the neuroanatomical organization underlying the neural coding that integrates
hypothalamic signals is poorly understood. The functional diversity of the hypothalamus suggests
that circuitry for these responses share common anatomical space, creating to some extent a need
to parse out these anatomical connections within the context of each behavioral and autonomic
response. In order to provide context about the importance of the anatomical aspects of this study,
the next sections will expand on the anatomy and functional importance of three feeding-related
neuropeptides found to be expressed in the hypothalamus, beginning first with alpha-melanocytestimulating hormone (αMSH), which is a part of the larger melanocortin neuropeptide system.
I.1. Melanocortins
The melanocortin family of peptides refers to those peptides generated when proopiomelanocortin (POMC) precursor protein is proteolytically processed by protein convertases
(PCs) into a number of smaller polypeptide hormones (Chretien and Mbikay 2016). This family
of peptides was the first reported to produce proteins with varying functions coming from the same
precursor protein. These peptides include adrenocorticotropic hormone (ACTH), γ-lipotropin (γLPH) and β-lipotropin (β-LPH), corticotropin-like intermediate peptide (CLIP), β-melanocyte
stimulating hormone (βMSH), γ-melanocyte stimulating hormone (γMSH) and αMSH (Chretien
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and Mbikay 2016, Cone 2005). Long before it was known that αMSH was derived from POMC,
this peptide had already been isolated from pig pituitary glands, when Dr. Aaron B. Lerner’s group
at Yale University School of Medicine did so in 1955. Two years later, the Lerner group published
the amino acid sequence of αMSH. In 1979, Nakanishi and colleagues published the entire
sequence of its precursor protein, ACTH-β-LPH precursor, which is now referred to as proopiomelanocortin (POMC). POMC-expressing neurons can be found in a variety of hypothalamic
nuclei; however, a large portion of αMSH immunoreactive (αMSH-ir) somata can be found within
the arcuate hypothalamic nucleus (ARH), with few somata crossing over into neighboring areas
(Guy et al 1982, Kiss et al 1984, Jacobowitz et al 1978). αMSH-ir fibers, on the other hand, can
be found throughout various regions of the brain; however, they are distributed in greater densities
within the periventricular (PV), paraventricular (PVH) and dorsomedial hypothalamic (DMH)
nuclei. The distribution and POMC origin of αMSH were known far before its physiological
effects, which were not characterized until the 1980s, when central administration of this
neuropeptide in different studies was reported to affect sexual behaviors and to suppress feeding.
Receptors for the melanocortins vary in function and localization though out the body: MCR1 has
been observed to be present in leukocytes and play a role in mediating inflammation. MCR2
mediates the effects of ACTH on steroid secretion. MCR3 and MCR4 are extensively found in the
central nervous system, where MCR3 has been linked to energy homeostasis and MCR4 to food
intake, among other functions. Finally, MCR5 is expressed in human peripheral tissues and is
involved in exocrine function (Yang, 2011). Since the 1980s, MCH has been found to play roles
in increasing aggression and anxiety, and in attenuating inflammatory responses in the body (Star
et al 1995, Rao et al 2003). However, within the nervous system, the major functional focus of
research for this neuropeptide has been on its role as an anorexigenic neuropeptide.
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I.2. Hypocretin/orexin
Hypocretin/orexin (H/O) is a neuropeptide that has two isoforms, referred to as hypocretins
1 and 2 (orexins A and B, respectively) which bind to two separate G-protein coupled receptors,
Hcrtr1 and Hcrtr2 (Ox1R and Ox2R, respectively) (Marcus et al 2001). The discovery of the
hypocretin/orexins was reported by two independent groups nearly simultaneously (Sakurai et al
1998, de Lecea et al 1998). In these initial descriptions, H/O-ir somata were found to be localized
in the DMH and lateral hypothalamic area (LHA), which was confirmed by later studies (Swanson
et al 2005, Hahn 2010). When administered intracerebroventricularly (icv) by the Sakurai group,
H/O led to increased food intake, which was the first behavioral function known for H/O (Sakurai
et al., 1998). Later studies determined that some of the effects that H/O has on feeding take place
through the modulation of reward pathways by way of projections to VTA dopaminergic neurons
in response to low glucose levels from fasting and weight loss (Borgland 2006, Sheng et al 2014,
Teegala et al 2018). Although H/O-ir somata are restricted to LHA and neighboring regions, H/Oir fibers were also observed throughout various regions of the brain including the locus coeruleus,
the raphe nuclei, and the pontine reticular formation as well as various hypothalamic regions, such
as the VMH, ARH, and PVH. The distribution of the receptors for H/O, as well as the axonal
distribution of this neuropeptide, have implied roles for H/O that go beyond just feeding.
Specifically, later studies demonstrated that, in addition to feeding, this neuropeptide plays a role
in wakefulness, arousal, addiction and drinking behaviors.
I.3. Melanin-concentrating hormone
The discovery of melanin-concentrating hormone (MCH) in 1983 came about as an effort
to find evidence for a peptide theory proposed by Hogben and Slome in 1931. This theory proposed
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that the pigmentation of amphibian skin was regulated by antagonizing “agencies” later discovered
to be the peptide neurotransmitters αMSH (lightening of the skin) and MCH (darkening of the
skin) (Kawauchi et al 1983). MCH was found to come from a precursor protein, pro-melanin
concentrating hormone (PMCH), which, when cleaved gives rise to MCH, neuropeptide- glutamic
acid-isoleucine (NEI) as well as neuropeptide-glycine-glutamic acid (NGE) (Bird et al 1990). Its
effects on skin pigmentation of fish were later found to be only one of many roles for this peptide
that is highly conserved across species. It was found in 1996 that when MCH was administered
intracerebroventricularly (icv) in rats, there was an increase in food consumption. Much like H/O,
somata that are immunoreactive for MCH are found mostly in the LHA and neighboring regions
in the rat. However, MCH-ir somata extend more dorsally into the zona incerta (ZI) and more
caudally into the posterior hypothalamus (PH), with MCH-ir axons found throughout the entirety
of the brain. The highest densities of MCH-ir axons have been reported in the cerebral cortex,
thalamus, amygdala, hippocampus, septum, basal ganglia, the superior and inferior colliculi,
parabrachial nucleus, periaqueductal grey, ventral tegmental area, raphe nuclei, interpeduncular
nuclei, and reticular formation as well as within the hypothalamus (DMH, anterior hypothalamic
nucleus (AHN), preoptic area, and LHA) (Nahon et al 1989, Bittencourt et al 1992, Swanson et al
2005, Hahn 2010). Much as with H/O, this widespread distribution of MCH-ir fibers throughout
the brain led researchers to hypothesize a variety of functions for this neuropeptide, many of which
overlap with the proposed and established functions of H/O. Although icv administration of MCH
did elicit an increased food consumption in sated rats, and the expression of this neuropeptide was
observed to increase with fasting (Qu et al 1996), there was no effect observed on normal body
weight, indicating that MCH has a role in food intake control but not in the regulation of body
weight (Rossi et al 1997). MCH has also been reported to affect behaviors such as drinking,
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reproduction and sleeping, as well as the endocrine functions of both the hypothalamic-pituitaryadrenal axis and the hypothalamic-pituitary-thyroid axis.
I.4. Anatomy of the hypothalamus
The hypothalamus is subdivided into three mediolateral zones (periventricular, medial and
lateral) containing different nuclei, each with their own connectional profiles (Simerly 2015). The
medial zone nuclei, for the most part, are very well defined in terms of their cytoarchitectural
organization, making their identification easier and more common in atlas representations (Simerly
2015). The lateral zone, however, has often been viewed as a large monolithic structure (e.g., in
the atlases of Paxinos and Watson, Paxinos and Franklin, and the Allen Reference Atlas) and is
usually not subdivided. The LHA, however, consists of different heterogeneous populations that
have been subdivided into 16 provisional cytoarchitecturally-defined subdivisions by Swanson
(2018). These subdivisions may become relevant when investigating the spatial distributions of
neuronal populations within the LHA, such as MCH and H/O. Studies examining the neuronal
activation of H/O-ir neurons have demonstrated that there are a larger number of activated H/O
neurons when rats are emerging from sleep and this difference seems to be regionalized, as medial
and perifornical H/O-expressing neurons were activated far more than those located more laterally
(Estabrooke et al 2001). This regionalization of function was also demonstrated to extend to
addiction, with subpopulations of H/O-expressing neurons projecting to ventral tegmental area
(VTA). Specifically, caudal VTA-projecting H/O neurons were found to be involved in morphineinduced conditioned place preference in rats with dependence while rostral VTA-projecting H/O
neurons were involved in condition place preference of non-dependent rats (Richardson and
Aston-Jones 2012). These regional effects of function are not limited to H/O, but are also observed
when examining the functions of MCH; for example, during activation in MCH neurons during
6

the induction of REM sleep. The distributions of activated MCH-expressing neurons during REM
sleep also has a distinct regional distribution (Verret et al 2003). However, none of these
aforementioned studies for either H/O or MCH use any type of reporting that would allow for these
different datasets to be placed into the same spatial model for comparison across cases and for
determining any patterns for these distributions that could become apparent from such a
comparison.
This lack of common spatial framework has also been apparent in studies of the
intrahypothalamic connections of feeding circuits. MCH, H/O and αMSH are neuropeptides which
have demonstrated interactions within the hypothalamus which could be related to feeding and
energy balance (Nahon et al 2006, Saper 2014). ARH αMSH-expressing neurons receive
peripheral signals from the pancreas and adipose tissues in the form of insulin and leptin,
respectively, which can lead to a decrease in feeding. These effects have been demonstrated to be
mediated downstream, in part, by the neuropeptides, H/O and MCH (Nahon et al 2006). Previous
studies have shown through the use of immunohistochemical stains that αMSH-ir fibers form
putative appositions with both H/O- and MCH-expressing neurons in the hypothalamus (Elias et
al 1998). Additional confirmation for these interactions came from follow-up studies which used
genetically encoded tracers to demonstrate that H/O-expressing neurons receive inputs from
αMSH-expressing neurons (Sakurai et al 2005). However, much like the functionally-defined
distributions of H/O- and MCH-expressing neurons, these datasets for αMSH-ir interactions with
these orexigenic peptides have not been mapped using atlas-based approaches. Therefore, since
they cannot be brought into registration with other datasets, the spatial distributions of their
interactions are difficult to compare at a sub-regional level within the hypothalamus. This could
mean that the subtle intricacies of intrahypothalamic communication may be eluding us simply
7

because the experimental data provided in the literature has not been brought into a common spatial
framework with enough precision to begin to see possible patterns that underlie such
communication.
I.5. Specific Aims
Specific Aim 1: To conduct atlas-based mapping of H/O, MCH and αMSH in the hypothalamus
using the Swanson reference atlas in order to determine novel patterns of co-spatial organization.
The distributions of αMSH, MCH and H/O neuropeptidergic signals have been extensively
characterized in various studies. Some of these studies have even mapped these peptides using an
atlas-based approach; however, there has not been an atlas-based analysis of these neuropeptide
distributions in a systematic way across various cases or in relation to one another in the same
brain. In the present study, the use of immunohistochemical stains for a combination of αMSH and
H/O across three animal cases will be used in order to generate maps showing areas of high and
low variability for the presence of immunoreactive fibers and somata throughout a major extent of
the anterior, and tuberal divisions of the hypothalamus. We aim to provide maps of these
distributions to help other researchers who use techniques that require the precise localization of
neurons for investigation of synaptic interactions, as is the case with techniques such as like patchclamp electrophysiology, electron microscopy and optogenetics/chemogenetics.
Specific Aim 2: To extend the predictive power of atlas-based mapping by identifying and
mapping the distributions of putative αMSH-ir axonal appositions with H/O- or MCH-ir cell
populations using the Swanson reference atlas.
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Studies like those conducted by Elias et al 1998 and others have demonstrated the presence
of putative appositions from αMSH-ir axonal fibers onto MCH- and H/O-ir cell bodies. These
studies – although demonstrating the presence of these appositions – did not give the discerning
reader a sense of the distributions or which regions display greater numbers of these sub-cellular
elements. This would make investigating their interactions difficult, as this would require prior
knowledge of locations where finding these possible synaptic interactions would be more likely.
By conducting a regional analysis of putative appositions throughout the dorsoventral and
mediolateral extents of the hypothalamus on an atlas-level basis, the aim here is to provide highspatial resolution distributions for these possible interactions. By contextualizing these data using
a common spatial framework, we are able to compare across different animal cases and provide
zones of high consistency for putative interactions. The use of these methods will allow for the
generation of the highest spatial resolution maps for distributions of these putative appositions,
aiding in the future exploration of the interactions between these two cell populations.
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Chapter II: Materials and Methods
II.1. Experimental subjects
Adult male Sprague Dawley rats (290–350 g body weight) were housed in a temperature
and humidity-controlled vivarium with a 12 h:12 h light:dark photoperiod (lights on at 7:00
A.M.). Animals were given access to food and water ad libitum. All protocols were approved and
sanctioned by the Institutional Animal Care and Use Committee of the University of Texas at El
Paso.
II.2. Transcardial perfusion and tissue sectioning
Between four and six hours after the onset of the light cycle, animals were deeply
anesthetized under 4% isoflurane (Vedco, St. Joseph, MO) in an induction chamber (Scienceware,
South Wayne, WI) prior to transcardial perfusion with ice-cold 0.9% saline. This was followed by
perfusion with 4% paraformaldehyde (PFA) dissolved in 0.05 M phosphate-buffered saline (PBS)
(pH 7.4 at room temperature). Following fixation, brains were then carefully removed and placed
in additional fixative solution (buffered 4% PFA), then stored in 0.05 M phosphate-buffered saline
(PBS) with 20% sucrose for 24 hours at 4°C. The brains were then rapidly frozen in supercooled
hexanes for long-term storage at –80°C. Prior to tissue sectioning, brains were blocked into
hindbrain and forebrain in order to acquire only the sections of the tissue needed. The remaining
blocked tissue was then frozen and stored at –80°C. Tissue was sectioned in the coronal plane at
30 μm thickness using a Reichert sliding microtome (Reichert, Austria, Nr. 15 156) fitted with a
modified freezing-stage (Brain Research Laboratories, Newton, MA; Cat#3488-RJ). Tissue
sections were collected as six 1-in-6 series and placed into 24-well plates filled with cryoprotectant
solution (30% ethylene glycol, 20% glycerol in 0.05 M sodium phosphate buffer) for storage at –
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20°C until further processing. The second tissue series collected was reserved for preparing a
cytoarchitectural reference series using Nissl staining, with the remaining tissue series reserved
for immunohistochemical analyses.
II.3. Histochemistry
II.3.1. Nissl Staining—Sections were removed from cryoprotectant solution and washed five times
for a period of five minutes (5×5) in netted well trays with 0.05 M Tris Buffered Saline (TBS)
solution (3.3% Tris HCl, 0.47% Tris OH in normal saline; pH 7.4 at room temperature) prior to
mounting them onto gelatin-coated slides (Simmons and Swanson, 1993). Sections were allowed
to air-dry overnight at room temperature prior to sequential dehydration in ascending ethanol
concentrations (50%, 70%, 95%, and 3×100% for 3 min each) and delipidized in xylene for 25
min. Sequential rehydration of the sections was performed in descending ethanol concentrations
(100%, 95%, 70% and 50% for 3 min each), and then rinsed with distilled water for 3 min prior to
staining with 0.25% thionine for 1 min and 30 sec. The tissue sections were then immediately
rinsed with distilled water and placed in 0.4% glacial acetic acid for 1 min to remove excess
thionine and differentiate the areas. Stained tissues were again sequentially phased through
progressively non-aqueous solvent solutions (50%, 70%, 95%, and 3 ×100% ethanol for 3 min
each). Sections were later cleared with xylenes for 25 min and finally coverslipped with
dibutylphthalate polystyrene xylene (DPX) mounting medium (catalog #06522; Sigma-Aldrich,
St. Louis, MO).
II.3.2. Immunoperoxidase Histochemistry (IHC)— Immunoperoxidase staining was performed on
a series of tissue sections adjacent to that of the Nissl-stained series. Sections were transferred in
a netted washing tray filled with 0.05 M TBS (25°C, pH 7.4) for five washes of five minutes each
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(5×5) in order to remove cryoprotectant. The netted tray containing the sections was then filled
with a solution of TBS containing 0.014% phenylhydrazine, which was allowed to mix with
sections for 20 min to suppress endogenous peroxidase activity. Sections were again washed 5×5
with TBS and placed in blocking solution (2% (v/v) normal donkey serum (EMD Millipore (now
MilliporeSigma), Burlington, MA; Catalog #S30-100ML; Lot #2510142); 0.1% Triton X-100
(Sigma-Aldrich; Catalog #T8352-500ML, Lot #MKBH4307V); in TBS) to incubate for one hour.
Sections were then transferred into a sterile 24-well plate containing primary antibody solution for
48–72 hours at 4°C (details outlined in Table 1). For the following procedure, biotin-conjugated
secondary antibodies were separated into two staining rounds to allow for independent staining
with 3, 3'-diaminobenzidine (DAB) (brown signal) (Sigma-Aldrich) and ammonium nickel (II)
DAB (dark purple signal). Sections were washed 5×5 and transferred to their respective secondary
antibody solutions containing biotinylated donkey-derived antibodies to incubate for 5 hours.
Sections were then placed in 5×5 washes in TBS and then into avidin-biotin-horseradish
peroxidase complex-containing solution (Vectastain Elite ABC-peroxidase kit, Vector
Laboratories, Catalog #PK-6100, RRID:AB_2336819; 0.45% v/v reagents A and B; 0.1% Triton
X-100 in 0.05 M TBS). Sections were then washed 5×5 and placed in their respective
immunoperoxidase solutions containing 0.1% w/v ammonium nickel (II) sulfate, 0.05% 3, 3'
diaminobenzidine, 0.005% (v/v) H2O2 and 0.05 M TBS, and then observed until an adequate signal
was obtained. Steps for secondary staining were then repeated for the second antigen, except the
DAB solution did not include ammonium nickel (II) (0.05% w/v DAB, 0.015% v/v H2O2 dissolved
in 0.05 M TBS). A final 5×5 wash was performed, and then sections were mounted onto gelatincoated slides and allowed to dry overnight at room temperature. Slides with mounted sections were
then dehydrated in ascending concentrations of ethanol (50%, 70%, 95%, 100% for 3 minutes
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each), followed by 25 minutes in mixed xylenes to defat the tissue. DPX (Catalog #06522; SigmaAldrich) mounting medium was then used to coverslip the slides.

II.4. Imaging and Image Alignment
II.4.1. Bright-field Imaging—An Olympus BX63 light microscope equipped with an DP74 color
camera with X-Y-Z motorized stage (Olympus Corporation, Center Valley, PA) driven by
cellSense™ Dimension software (Version 2.3) was used to image and stitch Nissl- and DABstained tissue sections. Hemi-sections corresponding to the same side of the brain for both sets of
tissues were imaged at ×10 magnification (N.A.,0.3) for alignment purposes. Another set of
photographs of DAB-stained tissues was obtained at ×100 magnification (N.A.,1.4) to demonstrate
individual putative appositions. An Olympus BX53 light microscope (Olympus Corporation,
Tokyo, Japan) was used to confirm and map the putative appositions for quantification. When
necessary, Adobe Photoshop (in Adobe Creative Cloud; Version CC 18.0.0; Adobe Systems, Inc.,
San Jose, CA) was used to adjust the brightness and contrast of the photomicrographs, and then to
later export the images as TIFF-formatted files.
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II.4.2.

Image

Alignment

and

Demarcation—High-resolution

images

of

bright-field

immunoperoxidase-stained sections, along with images of a reference Nissl-stained adjacent tissue
series, were imported into Adobe Illustrator (AI; Version CC 18.0.0; Adobe) as individual data
layers and aligned with one another using white matter tracts and vascular features in the tissue
sections to bring them into register, as described previously (Zséli et al., 2016). Images of Nisslstained tissues were adjusted for brightness or contrast when not optimally stained. Other than
rotation and scaling adjustments for alignment purposes, no other alterations were made for images
of the immunoperoxidase-stained tissues. In some instances, the adjacent Nissl-stained tissue
series was lost or too distorted to be faithfully aligned with its immunoperoxidase-stained tissue
counterpart (Figure 1). Data layer overlays were created in AI in which the boundaries of gray
and white matter regions for the reference images for Nissl-stained tissues were rendered and in
which immunoreactive cell somata (denoted by filled circles) and fibers (marked by solid lines)
were plotted for the antigens, αMSH, H/O, and MCH. Additional refinement of cell somata
denotation was performed when analyzing tissue sections under ×100 magnification in order to
increase accuracy of the cell counts in later steps.
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Figure 1. Schematic representation of the mapping process. From left to right, (A) an atlas template (Level
30) used to determine hypothalamic sub-regional boundaries on (B) Nissl-stained sections, based on
cytoarchitectural analysis, which are then overlaid onto (C) an adjacent tissue series from the same animal
which was immunoperoxidase-stained for relevant neuropeptides. Sections were overlaid using separate
layers in Adobe Illustrator and aligned with the use of fiducial landmarks on both stained sections. Images
were obtained at ×10 magnification and stitched using cellSense™ software. Please consult the Appendix
for an explanation of the abbreviations used in this figure. Scale bar in Panel C represents 200 µm and also
applies to Panel B

II.5. Analysis of Putative Appositions
Aligned Nissl and DAB files were used together as a guide to locate and observe each cell
body under a microscope at ×100 magnification (N.A., 1.25) for putative appositions. Whenever
a cell was identified to have a putative apposition, the color of the already mapped cell body would
be changed. If a cell was checked and not found to contain a putative apposition, the color of the
stroke would be changed to indicate that the cell had been analyzed. The following criteria were
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used to determine all putative appositions (Krimer et al 1997, Lambe et al 2000): 1. Clearly
identifiable cell body and fiber within the same focal plane;

Figure 2. Examples of criteria for putative appositions. A. The green box shows an example of a positive
putative apposition; an H/O-ir bouton is shown to be putatively contiguous with nNOS-ir cell body within
the same focal plane. B. The red box demonstrates an example of a negative putative apposition; a space
can be observed between an nNOS-ir cell body and H/O-ir boutons. Images obtained at ×100 magnification.
Scale bar in Panel A represents 5 µm and also applies to Panel B.

2. No visible space observed between the fiber and cell body in any focal plane; and 3. The fiber
can be followed in and out of focus as it contacts the cell body. (Figure 2 shows an example of
what is considered a putative apposition; for more examples, please see Figures 6 and 8).
II.5.1. Semi-quantitative analysis of cell counts—The total counts for cells containing putative
appositions for each neuropeptide were acquired by sub-region using the Lasso and Document
Information tools in Adobe Illustrator (Adobe Creative Cloud CS5) to count ellipses that had been
used to mark the presence of each cell. Similarly, cell counts for each peptide were acquired and
used to provide percentages of cells containing putative appositions with respect to the total
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number of cells by region. The analysis of cell bodies in this study is semi-quantitative, and
therefore, provides an assessment of the number of cells observed rather than a full representation
of each region (see Figures 7 and 9 for maps of putative appositions).
II.6. Translation of Data to the Atlas
Data from direct image overlays were translated to the Swanson rat brain atlas (Brain Maps
4.0; Swanson, 2018) using an approach as previously described (Zséli et al., 2016). Briefly, the
distributions of cells and fibers were examined in the context of orientation (fiber direction) and
positional relationship to the experimental tissue’s regional boundaries. Adjustments to
accommodate regional distortions between the experimental tissue and the atlas representation
were approximated and applied to the data, being careful to preserve the relative distributions and
orientations of the labeled elements.
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Chapter III: Results
III.1. Aim 1: To conduct atlas-based mapping of H/O, MCH and αMSH in the
hypothalamus using the Swanson reference atlas in order to determine novel patterns of cospatial organization.
In order to determine the spatial distributions of the data plotted in the maps generated in
this study, cytoarchitectural criteria were used to draw boundaries of hypothalamic sub-regions.
The criteria used to determine these boundaries are those used by Swanson (2004) and draw upon
a wide variety of studies for each of the hypothalamic sub-regions depicted. Briefly, these include
morphology, staining intensity, orientation, packing density and distribution as revealed in Nisslstained sections (Simmons and Swanson 1993), an example of which is shown in Figure 3, B. The
scope of the chemoarchitectural analysis performed includes atlas templates (atlas levels 23–30)
covering two of the four major rostrocaudal divisions of the hypothalamus (anterior and tuberal).
For each of these levels, the entire mediolateral and dorsoventral extents of the hypothalamus were
analyzed. Based on their cytoarchitectural boundaries, tissue sections were identified as
corresponding to one of the atlas levels observed in this study, which then allowed for the transfer
of data from immunohistochemically-stained sections to atlas templates. Before this, however,
boundaries that were established using an adjacent tissue series which was Nissl-stained are
overlaid onto the immunohistochemically-stained sections with the use of separate data layers in
the Adobe Illustrator platform (Figure 3). This allowed for the approximate locations of all
mapped cell bodies and fibers in this study to be determined and reported using atlas templates.
Three tissue series from different animals were each used in order to perform
immunohistochemical stains for combinations of αMSH+H/O (n=3) and αMSH+MCH (n=3),
respectively. The three cases that will be mapped for these αMSH+H/O combinations will allow
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for comparison of the presence of these neuropeptides across different subjects. This will allow
for statistical comparison to determine regions of lower and higher variability for presence of these
neuropeptides and, eventually, of the locations for putative appositions between α-MSH-ir fibers
and H/O-ir or MCH-ir somata, which will be discussed in further detail in the second aim of this
project. The use of immunoperoxidase staining protocols to facilitate the analysis of putative
appositions will also be discussed in the next section.

Figure 3. Examples of the quality of histology. (A and C). Representative sections stained for αMSH+HO
or αMSH+MCH, respectively, which show overlaid parcellations from (B). A nissl-stained section. All
three sections shown here represent three different adjacent tissue series from the same animal. Images
were taken at ×10 magnification. Please consult the Appendix for an explanation of the abbreviations

used in this figure. Scale bar in Panel A represents 200 µm and applies to all panels

III.1.1. Distribution of α-MSH-ir fibers throughout the hypothalamus
αMSH-ir fibers are more sparsely distributed in lateral structures; however, there is at least
a small representation of these fibers in each hypothalamic sub-region throughout the rostrocaudal
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extent of the analyzed levels. The highest concentration of fibers was observed in the medial and
perifornical portions of the hypothalamus, with structures such as the PVa, PVi, PVHap, PVHpv,
PVHmpd, PVHf, DMHa, DMHv and DMHp, having the most robust presence for αMSH-ir fibers.
There are also some medial zone regions that seem to noticeably lack αMSH-ir fibers, such as the
more caudally located VMHdm, VMHc, and more rostral parts of the AHN.
The distribution of αMSH-ir somata is strictly restricted to that of the ARH and
immediately adjacent regions such as the TUsv, beginning from level 27 and continuing through
the rest of the surveyed atlas levels. These distributions are consistent with previous reports (Guy
et al 1982, Kiss et al 1984 and Jacobowitz et al 1978).
III.1.2. Distribution of H/O-ir fibers and somata throughout the hypothalamus
The density for H/O-ir fibers varies throughout the rostrocaudal extent of the hypothalamic
atlas levels sampled in this study. More caudal levels have relatively equal distributions of fibers
throughout the mediolateral extent of the hypothalamus, with the most rostral level sampled – atlas
level 26 – demonstrating a higher density of fibers in the medial zone of the hypothalamus. Caudal
levels also contain a greater number of fibers which remain within the image plane for longer
distances and which have a higher presence in more dorsal regions (Figure 4, E–H). This suggests
that these fibers travel in a more lateral direction than the shorter fibers of more rostral sections,
which are likely traveling in a rostrocaudal direction.
Consistent with previous studies, the highest density of cell bodies for H/O were observed
within atlas levels 29 and 30, with the most anteriorly sampled cell bodies observed at level 27 for
this specific case; however, previous studies have reported H/O-ir cell bodies as anterior as level
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26 (Swanson et al 2005, Hahn 2010). These cell bodies form a band that spans several perifornical
sub-regions, including the LHAjd, LHAs, LHAd and LHAma.
III.1.3. Possible synaptic interactions zones for αMSH-ir fibers and H/O-ir somata
By mapping the same neuropeptide combinations across three different animals, we are
able to analyze patterns across subjects, in order to determine what regions might have areas of
consistent peptide expression and, moreover, areas of consistent co-localization of
immunoreactive fibers and cell bodies which have been dubbed as “possible synaptic interaction
zones (PSIZ)” by previous studies in our laboratory (Wells 2017). In this study, three animals were
used for testing a neuropeptide combination of H/O+αMSH immunostains, which will allow for
the generation of maps demonstrating regions of high and low variability in peptide co-spatial
occupancy in common sub-regions. Being able to identify these PSIZs with higher confidence will
allow researchers who want to study the interactions of these neuropeptides to save time and effort
and to narrow their search fields using more refined methods such as patch-clamp
electrophysiology, optogenetics and electron microscopy; as they would be able to scan smaller
regions in order to find neurons with the synaptic interactions they are seeking to study further.
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Figure 4. Representative maps for alpha-melanocyte stimulating hormone (αMSH) and hypocretin/orexin
(H/O) chemoarchitecture from levels 23–30. Circles were used to denote neurons and lines for neuronal
fibers. The BST sub-region is not part of the hypothalamus and was therefore not analyzed; in order to
avoid the assumption that this region is devoid of neuropeptide signal it was grayed out. Blue was used to
represent αMSH and red for H/O. Legends at the top left corner of Panels A and G represent the colorcoding scheme for each neuropeptide shown. Data were translated onto the rat brain atlas templates from
Swanson (Brain Maps 4.0; Swanson, 2018) and arranged from rostral to caudal: the atlas level is located at
the bottom left corner of each panel. See Appendix I for a full list of abbreviations. N=1.

III.1.4. Distribution of MCH-ir fibers and somata throughout the hypothalamus
Fiber staining for MCH was not as robust as that observed for H/O-ir fibers; because of
this, we are unable to comment in detail on the distribution of MCH-ir fibers. MCH-ir cell bodies
are situated further dorsally than are H/O-ir cell bodies, with a large group of cells found within
the ZI. The presence of MCH-ir cell bodies within the ZI persists throughout the rostrocaudal
extent of sampled atlas levels containing this structure, beginning at level 26, where lower densities
of MCH-ir cell bodies can be found (Figure 5, D) and which increase in density at more caudal
levels. Contrary to previous reports (Hahn 2010, Swanson et al 2005), cell bodies were found to
localize within the PVHmpd and PVHlp at level 27 within this single case. The presence of MCHir somata within the PVH may not be a common occurrence and could be a region of high
variability for the presence of MCH; however, this study does not contain enough animals to
explore that possibility. Consistent with previous reports, there is a band of MCH-ir cell bodies
that extends across sub-regions surrounding the dorsal area of the pofh in regions such as the
LHAjd, LHAs, LHAd, LHAma, LHApc and LHAvl. Other areas ventral to the fornix where groups
of MCH cell bodies localize are the DMHa, DMHv, LHAjvv and LHAjvd. This is a similar pattern
to that observed for the distribution of H/O-ir cell bodies. In contrast, MCH-ir cell bodies extend
further laterally at atlas levels 28–30. MCH-ir cell bodies were not observed to localize to more
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ventral sub-regions such as the VMH, ARH TUte, TUsv and TUi, for those levels where cell bodies
were present in other areas.
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Figure 5. Maps for alpha-melanocyte stimulating hormone (αMSH) and melanin concentrating hormone
(MCH) chemoarchitecture from levels 23–30. Circles were used to denote neurons and lines for neuronal
fibers. Blue was used to represent αMSH-ir cell bodies and fibers. Orange was used for MCH-ir cell bodies
and fibers. Legends at the top left corner of Panels A and G represent the color-coding scheme for each
neuropeptide shown. Data were translated onto the rat brain atlas templates from Swanson (Brain Maps
4.0; Swanson, 2018) and arranged from rostral to caudal: the atlas level is located at the bottom left corner
of each panel. See Appendix I for a full list of abbreviations. N=1.

III.2. Aim 2: To extend the predictive power of atlas-based mapping by identifying and
mapping the distributions of putative αMSH-ir axonal appositions with H/O- or MCH-ir cell
populations using the Swanson reference atlas.
Using the Adobe Illustrator files containing the annotated images of the
immunoperoxidase-labeled material as a reference, stained tissue sections were analyzed under
×100 magnification in order to determine which of the cells contained putative appositions
according to the criteria outlined in the Methods. By using the annotated images, we can ensure
that the cells we observed to contain putative appositions could be overlaid onto the
cytoarchitectural boundaries determined by our analysis of Nissl-stained sections, as was
performed for Aim 1. This procedure allows us to demonstrate the spatial distributions of these
putative appositions using the same spatial framework to qualitatively depict these distributions
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(Figures 7 and 9). Most putative interactions observed contained one or two boutons; however,
some were observed to involve more than two boutons that were seemingly in contact with the
analyzed soma.
III.2.1. αMSH-ir fibers– H/O-ir somata: Distributions of putative appositions
Spatial distributions
of

H/O-ir

somata

containing

putative

appositions

from
fibers

αMSH-ir
mostly

correlated

with areas where coexpression of H/O
and αMSH was in
high

density.

The

majority of putative
Figure 6. Examples of putative appositions of α-MSH-ir fibers with H/O-ir
somata. (A). Stitched image, at ×10 magnification, of a DAB-stained section with
purple dots depicting the location of H/O neurons with positive putative
appositions through the hypothalamus. (B–E). Images at ×100 magnification
taken with a Samsung Galaxy S10+ through an Olympus BX53 microscope
showing α-MSH-ir fibers in the same focal plane as H/O-ir somata. These are the
visual criteria taken into consideration when surveying tissues to identify putative
appositions.
Scale
bar
in
Panel
A
represents
200
µm.

appositions
mostly

were
located

medially and did not
extend

to

lateral

regions (Figure 7,
level 29 shows an illustrative example of this). DMHa, LHAjd, and LHAs were some of the areas
showing the highest density of putative appositions. The LHAs was one of the areas containing a
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high density of H/O-ir cell bodies through levels 27–30, but only a small portion of those cells
showed any putative interactions with α-MSH-ir fibers. In fact, level 28 had no putative
appositions in the LHAs, even though there were a number of H/O-ir cell bodies present. Figure
5 F and G illustrates a uniform distribution of H/O-ir cell bodies and αMSH-ir fibers, eliminating
the possibility that the absence of interactions was due to the fibers or cell bodies not being
properly stained. Other example areas where the same labeling can be observed were the LHAd
and LHAvl at level 30.

Putative Appositions

Level 24

Level 23

H/O Cell Bodies

27

Putative Appositions

Level 27

Level 26

Level 25

H/O Cell Bodies

28

Putative Appositions

Level 30

Level 29

Level 28

H/O Cell Bodies

29

Figure 7. Representative maps for hypocretin/orexin (H/O) cell body distribution (left column) and
distribution of the subset of those cells receiving possible synaptic input from αMSH-ir fibers (right
column). Distributions from levels 23–30 are shown in a rostral to caudal atlas level organization, from top
to bottom. Circles were used to denote neurons in both sets of maps. Red is used for H/O and pink is used
for those H/O-ir cells that were considered to contain putative appositions from αMSH-ir fibers when
analyzed under the oculars at ×100 magnification. Data were translated onto the rat brain atlas templates
from Swanson (Brain Maps 4.0; Swanson, 2018). See Appendix I for a full list of abbreviation. N=1.

III.2.2. αMSH-ir fibers –MCH-ir somata: distributions of putative appositions
Unlike H/O, the presence of MCH-ir putative appositions did not correlate with the
presence
neuropeptide

of

the
at

all

levels. A smaller number
of MCH-ir cell bodies
were

found

putative

to

have

appositions

when compared to H/Oir cell bodies. MCH-ir
somata were observed in
the ZI, LHAad, LHAjp,
and AHNc (Figure 9,

Figure 8. Examples of putative appositions of α-MSH-ir fibers and MCH-ir
somata. (A). Stitched image, at ×10 magnification, of a DAB-stained section Level 26). Yet none of
with green dots depicting the location of MCH neurons with positive putative
appositions through the hypothalamus. (B–E). Images at ×100 magnification these were found to be
taken with a Samsung Galaxy S10+ through an Olympus BX53 microscope
showing α-MSH-ir fibers in the same focal plane as MCH-ir somata. Scale bar
positive for putative
in
Panel
A
represents
200
µm.

appositions. This trend
was observed throughout the most rostral levels containing MCH-ir somata (atlas levels 26 and
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27). However, levels 28 and 29 shown a more lateralized distribution of putative appositions along
perifornical regions. The one level that breaks this pattern by having a more periventricular
distribution is level 30, although there is a small number of putative appositions located more
laterally. Regions with a consistently large number of putative appositions at more than one atlas
level include the LHAs, LHAd, LHAma, and LHAjvd. One region worth highlighting is the LHAd,
which displayed the largest number of MCH-ir somata, but did not contain many putative
appositions. Many of these differences could be caused by the lack of αMSH-ir fibers located in
the more lateral zone sub-regions of caudal levels, with higher densities found in more
periventricular zone nuclei.
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Putative Appositions

Level 25
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Putative Appositions

Level 28

Level 27

Level 26

MCH Cell Bodies
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Putative Appositions

Level 30

Level 29

MCH Cell Bodies

Figure 9. Maps for melanin-concentrating hormone (MCH) cell body distribution (left column) and
distribution of the subset of those cells receiving possible synaptic input from αMSH-ir fibers (right
column). Distributions from levels 23–30 are shown in a rostral to caudal atlas level organization, from top
to bottom. Circles were used to denote neurons in both sets of maps. Orange was used for MCH and green
was used for those MCH-ir cells that were considered to contain putative appositions from α-MSH-ir fibers
when analyzed under the oculars at ×100 magnification. Data were translated onto the rat brain atlas
templates from Swanson (Brain Maps 4.0; Swanson, 2018). See Appendix I for a full list of abbreviations.
N=1.
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III.2.3. Semi-quantitative analysis of putative appositions
Semi-quantitative cell counts were manually performed for each of the hypothalamic subregions throughout the extent of the levels analyzed. These cell counts were performed using the
atlas maps presented in Figure 9. These atlas maps contain each of the hand-annotated cell bodies
for both chemoarchitecture as well as putative appositions from immunoperoxidase-stained
material. Annotated cell bodies were placed by examining their photomicrographs, and these cell
body annotations were later refined as putative apposition analysis was carried out under ×100
magnification in order to increase the accuracy of cell counts, with special care taken to ensure
that each cell was placed in their respective hypothalamic sub-regions. The data obtained from
these counts provide information about the relative proportions of cells located in each
hypothalamic sub-region and the amounts of those cells which contain putative appositions. In
combination with the spatial distributions of putative appositions, the semi-quantitative data given
here allow for enhanced analysis of the data presented.
III.2.3.1 Single representative case analysis
When observing the percentages of distributions for putative appositions by level, it was
found that H/O received the highest percentage of putative appositions with αMSH-ir elements in
level 29 (52%), which is consistent with the percent of total H/O-ir neurons found in level 29
(58%: Figure 10 B). This, however, only represents 34% of the total number of H/O-ir neurons
found in level 29. Of these neurons containing putative appositions in level 29, the regions found
to contain the most putative appositions were the DMHa (33%), LHAjd (25%) and LHAs (18%).
Across all levels, it was observed that the three hypothalamic sub-regions containing the most
appositions of αMSH-ir fibers onto H/O-ir cells were the LHAjd, DMHa and LHAs.
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Interestingly, putative appositions of αMSH-ir fibers with MCH-ir cells, had the highest
percentage at level 28 (46%), which does not contain the highest percentage of total MCH-ir cells
(22%), as compared to level 30 (32%: Figure 10 D). The number of putative appositions in level
28 accounts for 29% of the total number of MCH-ir neurons at level 28. The regions with the
highest percentage of putative appositions for level 28 are the LHAs (37%) and LHAd (22%). The
fact that the LHAs at level 28 has the highest number of raw putative appositions of any single
sub-region at any single level, accounting for 65% of the total number of MCH-ir cells in this subregion, is also of note. Overall, across all levels, the regions with the greatest number of αMSH–
MCH putative appositions were the LHAs, LHAd and LHAjvd.
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B

C
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Figure 10. Quantification for putative appositions from αMSH-ir fibers onto H/O- or MCH-ir somata.
Panels A and C show bar graphs of the total counts for H/O- and MCH-ir somata, respectively, containing
putative appositions from αMSH-ir fibers. The counts are subdivided by color in order to demonstrate how
many cells from each sub-region were found at each atlas level analyzed. N=1. Panels B and D demonstrate
pie charts for the percentages of total putative appositions found at each atlas level analyzed. N=1. Please
consult the Appendix for a list of terms corresponding to the abbreviations in these graphs.
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Figure 11. Bar graph and dot plot representations of relative percentages for H/O- (A and B) and MCH-ir
(C and D) somata found to contain putative contacts from αMSH-ir fibers. Please consult Appendix I for
a full list of terms corresponding to the anatomical abbreviations shown on these charts. Charts provided
courtesy of Dr. Sivasai Balivada of the Khan laboratory.

III.2.3.2 Analysis across multiple cases
The trends observed in the counts from the representative case used to generate the graph
of H/O-somata containing putative appositions from αMSH-ir axonal fibers in Figure 10 (A and
B) hold when comparing them to the results for cell counts across regions of three cases. Observing
the average percentages, by level, for H/O-ir somata with putative appositions from αMSH-ir
fibers, we found that the percentages change with a range from 2–10%; yet, relative distributions
of these remained constant with those reported in Figure 10 (B). When comparing sub-regions
containing the largest average counts for these same putative appositions, we observed that the
average counts are also very similar to that of the representative case. Most importantly, we
observed that the top five areas remain constant, but changed in order: LHAs (30 ± 6.1 somata),
LHAjd (28 ± 1.9 somata), DMHa (22 ± 1.39 somata), LHAd (21 ± 3.1 somata), and DMHp (5.3 ±
1.7 somata). Overall, this consistency between the representative case and averages across cases
allows us to state with some degree of confidence that these regions will likely remain consistent
when examining putative appositions from αMSH-ir fibers onto H/O-ir somata across different
animals. In contrast, when observing the number of MCH-ir somata with putatively apposing
αMSH-ir fibers in the representative case (Figure 10C, D), we observed that the trends of levels
with the highest average putative appositions shifts to an almost equal distribution from levels 28–
30, with 33%, 30% and 35% respectively, of average counts when compared across cases. Similar
to what we observed with αMSH–H/O putative appositions, the top three regions in Figure 10 (C)
are the same top three regions when we take the average of MCH-ir somata with appositions across
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all three cases; although we also observe that their order based on counts is rearranged.
Specifically, when observing the average number of putative appositions between MCH-ir somata
and αMSH-ir fibers across hypothalamic subregions, the LHAd (22 ± 4.72 somata) contains the
highest average with the LHAs (18 ± 3.7 somata) containing the second-highest average number
of putative appositions, and finally, the LHAjd (16.33 ± 3.7 somata) with the third-highest average
number of putative appositions.
III.2.3.3 Analysis of relative percentages
As we shift our analysis from observations of the total number of somata with appositions
from αMSH-ir fibers to the relative percentages of these, we have confirmation of the general
trends observed in the counts, while at the same time being offered a new perspective on how we
interpret these data. Taking a quick survey of Figure 11, we are quickly able to observe that the
same areas that contain the highest numbers of putative appositions have the highest percentages
of these which is expected. However, in this same figure, we are also clearly able to see that H/Oir somata had a much higher relative percentage of appositions with αMSH-ir fibers when
compared to MCH-ir somata. This can be observed both across regions and across levels.
Similarly, we gain new insight when looking at the relative percentages of H/O-ir somata with
apposing αMSH-ir fibers. Here, we observe that even though the LHAd, LHAs and LHAjd contain
the highest percentages of total appositions, these coincide with the highest percentages of H/O-ir
somata across cases. However, the DMHa, DMHp and DMHv become a lot more interesting when
taking into account that even though they contain a lower percent total of H/O-ir somata, a much
higher percentage of these have apposing αMSH-ir fibers. This implies that those H/O-ir somata
within the subregions of the DMH are seemingly more directly targeted by αMSH-ir fibers. A
similar trend can be observed when analyzing the relative distribution of appositions across levels,
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where even though levels 26 and 27 contain lower percentages of appositions, these account for a
higher percentage of the total H/O-ir somata within those levels. Similar results are apparent when
we analyze the relative percentages of MCH-ir somata with apposing αMSH-ir fibers. Even though
the LHAd, LHAs, and LHAjd contain the highest percentages of these putative appositions ,we
can appreciate that these account for a very low percentage of total MCH-ir somata located within
these regions. Interestingly, when we observed the DMH, even though there are very few MCH-ir
somata within these subregions, most of these had apposing αMSH-ir fibers. Interpretation of these
results, however, is difficult, as it could be that these have a stronger physiological role because
there are so few of them or it could be that they happen so infrequently that there is no major
functional effect from these. The most obvious take-away from these data is the obvious difference
in the targeting of H/O-ir somata from αMSH-ir fibers when compared to MCH-ir somata. It would
appear that there is a stronger relationship between αMSH-ir fibers and H/O-ir somata which may
or may not have some physiological significance.
Chapter IV: Discussion
IV.1. Trends
The mapping of αMSH has been performed previously (Jacobowitz and O’Donohue et al 1978).
However, these maps were not created in relation to any standardized atlas, which means that
direct comparisons between our data and those data are not able to be performed in a
straightforward way. This point aside, the hypothalamic regions where they found αMSH-ir fibers
are in general agreement with those being reported in the current study. As far as the presence of
αMSH-ir somata is concerned, it was also found to localize to the ARH and immediately adjacent
areas. Overall, the study presented here provides a general confirmation of the study performed by
J. D. Hahn (2010), and extends it by providing detailed distributions of the fiber systems in addition
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to the cell body distributions for the neuropeptides examined. In his study, Hahn mapped H/O- and
MCH-ir somata distributions across hypothalamic levels 25–33 of the Swanson rat brain atlas. In
that study, the goal was to show possible differences between various subsets of neurons in the
LHA-expressing H/O or MCH neuropeptides. One major difference between the maps shown here
and those in Hahn 2010 is a difference in the number of animals represented on the maps furnished.
Hahn 2010 represents five animals together on one set of maps, while in the current study we have
one representative case per map, which makes a direct level-by-level visual comparison in
quantitation difficult. Taking this point into consideration, we are still able to make comparisons
in the trends observed. Here, we decided to represent only one case in order to be able to observe
the numbers and trends of these cell somata with less visual clutter and to provide the reader a
realistic expectation of what s/he would observe when performing IHC in a single animal. When
examining similarities between our study and that of Hahn 2010, we find that levels 28 and 29 are
the levels which contain the highest number of H/O- and MCH-ir somata. However, when
examining level 28, it is worth mentioning that the LHAjd had the highest concentration of H/Oir somata clustered closely to the pofh in Hahn 2010, while in the present there are only two
neurons in the immediate area of the pofh. Similarly, when examining level 30, we can observe
that the LHAvl in Hahn 2010 paper contains no H/O-ir somata, while here we see that this subregion is one with a significant representation of H/O-ir somata at level 30.
Turning our attention to MCH, we are able to observe that the most rostral presence of MCH is
located within level 25 in the ZI of Hahn 2010 with only one soma present, while here we did not
find any MCH-ir somata before level 26. The ZI has a consistent presence of MCH-ir somata
across levels 26–30; however, a subtle but noticeable difference is observable at level 26, with
MCH-ir neurons concentrating in the more lateral ZI in the present study while the presence of
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these is found in the more medial ZI in Hahn 2010. Another more notable discrepancy between
the current study and that of Hahn 2010 is the presence of MCH-ir somata in the PVH. Hahn makes
specific mention of the absence of MCH-ir somata within any subdivision of the PVH, which is
also consistent with the observations made in the published work of Saper et al 1986 and Broberger
et al 1998. In our study, we are able to observe a sizeable representation of MCH-ir somata
throughout the PVH at level 27, specially within the PVHmpd and PVHlp, which show the same
number of somata. There are a few possible sources for the variability between these two sets of
studies. There always exists the possibility that there was a difference in the way that the two
studies performed their mapping, with the most likely area of variation being the parcellation step.
This, however, seems unlikely, as both sets of studies were conducted using the same criteria for
defining what constitutes a cytoarchitectural boundary with respect to the PVH. Another possible
source of variability is that there was a difference in the neuropeptide that was being
immunocytochemically stained. This could be of consideration because MCH is derived from the
same precursor pre-melanin concentrating hormone (PMCH) as other hypothalamic peptides NEI
and NGE. If there was a discrepancy in the cross-reactivity of our MCH antibody, there is a chance
that we are also looking at the presence of NEI or NGE, with the most likely of these being NEI.
Previous studies demonstrated that both NEI and MCH have been observed to co-express within
the same regions of the hypothalamus including the LHA and ZI (Bittencourt et al 2008). The fact
that both neuropeptides co-localize gives us reason to believe that this will not be a concern.
However, in order to confirm that we are only detecting the presence of MCH-ir somata, we have
recently received the same antibody that was used by Bittencourt et al 1992 and which has been
confirmed to have exclusive specificity to MCH. This will be a future direction that will be carried
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out in order to strengthen the present study and will also be included when these data are submitted
for publication.
Other similarities in trends across studies can be observed in the immediate regions surrounding
the AHN at level 27, where it would seem that MCH has minimal representation within the AHN
and yet there is a large number of MHC-ir somata directly surrounding these sub-regions. Even
more consistency across studies can be seen at level 28, which shows the highest number of MCHir somata in both studies. This consistency even carries into the regional localization of the MCHir somata, where they were observed within the LHAs, LHAjd, and LHAma. If we assess
similarities by level, we observe that out of the levels which overlap in both studies, MCH-ir
somata have the most consistent presence at levels 29 and 30. Level 29 MCH-ir somata are located
mostly in the lateral zone, with the LHAs, LHAd, LHAma, and LHAjvd containing most of these,
with a comparatively lower presence in the LHAjd. In the same way, level 30 of both studies shows
a preference for perifornical regions, with the highest presence of MCH-ir somata being found in
the more lateral LHAd and LHAma sub-regions.
While Hahn 2010 represents multiple animals in one set of maps, the relative visual densities and
trends can be compared and show a high degree of consensus with few regions of major
discrepancies with the current study. A comparison of this nature is possible because the datasets
were mapped to the same standardized atlas, thus bringing them into register. Another possible
future direction for more closely comparing our data with his study would be to obtain the raw
data and counts from the Hahn study so they can then be used to more directly compare
distributions across animals and generate maps that show more precise trends of consistency across
cases.
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IV.2. Technical and methodological considerations
IV.2.1. Mapping
The size and scope of the present study necessitated the input of multiple students who participated
in the generation of the peptide maps presented here. While beneficial, this multi-user mapping
effort requires careful considerations, since having a team working on generating maps introduces
additional sources of variability, including possible variance between students. For our study,
major sources of variability can be traced to two transformations of data: the first of these is the
transformation of the raw data from the photomicrographs of the tissue sections and the second of
these is the translation of data from the photomicrographs to the corresponding Swanson atlas. As
explained in the Methods section, the plotting of fibers and somata was performed by
superimposing the Nissl parcellation file and photomicrographs of the DAB stain. Ellipses and
hand-drawn lines were then placed in a separate data layer overlaid on the data layer holding the
DAB photomicrograph. This arrangement allowed each student to have his or her own
interpretation of the amount of representation that should be given to each neuropeptide. This leads
to a range of representations between students, which we observed to become apparent in one of
two ways: some would be overly detailed and preferred a more one-to-one representation of every
single fiber/mark on the photomicrograph, while others would take a more abstract approach, being
more mindful of representing the trends that were present rather than creating a one-to-one
representation. To mitigate the variance introduced by these different interpretations, student maps
were continuously checked by more senior graduate students. Upon completion of mapping,
students were provided feedback, with the goal of helping them improve their representation of
the data. It must be mentioned, however, that this was of serious concern only with the
representation of fibers. This is due to the further refinement of somata counts and placements that
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was performed with the use of a microscope at ×100 magnification, when the putative apposition
checks were taking place. During these checks, all erroneously marked somata were removed and
any somata which were not marked were then added during this process. This process provided us
with more certainty about the representations of somata in this study.
Similarly, when examining the translation of data to the Swanson atlas, there is a similar
introduction of interpretive variability. The effects of these are not of major concern when
considering intra-regional representation, because of the method used to transfer these data.
Specially, when moving ellipses and lines from the photomicrograph to the Swanson atlas
templates, all of these elements within one sub-region are group-selected using the Lasso Tool in
Adobe Illustrator and copied and pasted onto the atlas template. These are then transformed as one
unit to preserve the trends observed in the photomicrographs of the tissue.
In order to account for these variations, we have devised a rubric that will assess the mapping of
all those who have participated in the generation of these maps. A blind study with a set of controls
to score the two transformation steps of data will be performed with the help of three experts.
These experts are individuals who have had much experience performing the techniques of
immunohistochemistry and mapping and did not participate in generating any of the data presented
here. These control studies are separated into three categories: control tests for the quality of
immunocytochemical stain and photomicrography, for raw mapping, and for translation of the data
to Swanson atlas maps. Cases will be separated into pairs (A and B) that will allow for assessment
of these three categories. Rubrics will be provided to each scorer which will give a score ranging
between 1 – 3 with: 1 = no variability between the pair, 2 = some discrepancies between the pair,
and 3 = variability between the pair is very high. These scores will help validate the interpretations
of the individuals who were involved in the staining of the tissues and in the mapping of the
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neuropeptides presented in this study, thus providing a measure of reliability to the mapping
process and ensuing its reproducibility. This is currently underay and is another near-term future
direction that will be realized once these data are submitted for publication.
IV.2.2. Cell counts and putative appositions
Cell counts were performed on data that had already undergone translation to the Swanson atlas.
With the use of the Lasso tool in Adobe Illustrator, all ellipses within a specific sub-region were
highlighted and a readout for the selections was given by the Document Info tool. This readout of
ellipses is the number that was used for the cell counts reported in this study. Due to the
methodology used here, there were some instances where ellipses placed on the border of two subregions could be counted for either sub-region; this could lead to a small discrepancy in cell counts
between regions. Once these numbers were proofread, the processed averages and percentages by
sub-region and total level were performed with the use of Excel.
Putative apposition analysis adds yet another area for some interpretive variation between
individuals involved in this process. To minimize this, criteria for the identification of appositions
were generated based on previously published studies that reported putative-apposition analysis
using bright-field microscopy as a visualization method. The use of these criteria facilitates
discussion between those who performed putative apposition analysis, which in turn allows for
consensus of what types of somata would be considered to contain putative appositions and which
would be disregarded. Each student participating in this process practiced under the supervision of
a graduate student who confirmed any judgments that were considered difficult by the student.
This allowed for discussion and consensus among those performing the studies. However, it must
be acknowledged that this does not remove variability completely. The consistency of areas
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containing putative appositions gives us some degree of confidence that there was a general
agreement among all those who performed this analysis.
It must also be acknowledged that the use of bright-field microscopy is limited when it comes to
the magnification that can be achieved. This means that the putative appositions that we are able
to observe may not be synaptic in nature. In order to further explore if these putative appositions
are synaptic, we would have to perform electron microscopy in order to confirm whether the
identified appositions formed true synapses. This is yet another future direction that is being
addressed currently and will be included once these data are submitted for publication. The maps
we have generated here have been provided to a collaborator, who will be providing us with
electron microscopy photomicrographs that will be informed by the patterns that we have observed
in this study.
There is also a time-of-day effect that must be taken into consideration when analyzing the
distributions of each of these neuropeptides, especially with αMSH, which has been documented
to have distinct diurnal patterns (O’Donohue et al 1979). In our study, this variable was accounted
for, since all animals were perfused at 3–5 hours after the start of their light phase.
IV.3. Concluding statement
The goal of this study was to provide a comprehensive overview of the cytoarchitectural
distributions for H/O-ir and MCH-ir cell populations with respect to αMSH-ir fibers. In
performing this type of identification and localization, one can analyze areas that contain regions
of higher probability for finding putative appositions between neuropeptidergic systems. These are
referred to here as “probable synaptic interaction zones” (PSIZs), which our laboratory will be
generating maps for as we expand the work presented here. Even though the presence of putative
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appositions from αMSH-ir axonal fibers onto H/O- and MCH-ir cell bodies has been reported
previously (Elias et al. 1998; Sakurai et al., 2005), we have provided high-spatial resolution maps
which are based on a common neuroanatomical framework (the Swanson atlas), which is
something that previous studies had not provided. Additionally, we were able to perform
quantification of these interactions and analyze their spatial distributions across the levels sampled
here. While MCH- and H/O-ir cell bodies were also found at more caudal levels, which we did not
map, detailing all of their distributions was outside the narrow scope of the present study. Overall,
the maps that were generated here will facilitate further exploration of interactions between
(presumed to be primarily ARH-originating) αMSH-ir fibers with H/O-ir and MCH-ir
neuropeptidergic populations of the medial and lateral zones of the hypothalamus. Investigation
using functional techniques that require targeting of specific neuronal populations will benefit
from the maps generated here. Moreover, the datasets presented provide novel and innovative
anatomical data for the anterior and tuberal divisions of the hypothalamus.
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Appendix: List of Neuroanatomical Abbreviations
AHN

anterior hypothalamic nucleus

AHNa

anterior hypothalamic nucleus anterior part

AHNc

anterior hypothalamic nucleus central part

AHNd

anterior hypothalamic nucleus dorsal part

AHNp

anterior hypothalamic nucleus posterior part

ARH

arcuate hypothalamic nucleus

DMH

dorsomedial hypothalamic nucleus

DMHa

dorsomedial hypothalamic nucleus anterior part

DMHp

dorsomedial hypothalamic nucleus posterior part

DMHv

dorsomedial hypothalamic nucleus ventral part

l

internuclear hypothalamic area

LHA

lateral hypothalamic area

LHAad

lateral hypothalamic area anterior group anterior region dorsal zone

LHAai

lateral hypothalamic area anterior group anterior region intermediate
zone

LHAav

lateral hypothalamic area anterior group anterior region ventral zone

LHAd

lateral hypothalamic area middle group lateral tier dorsal region

LHAjd

lateral hypothalamic area middle group medial tier juxtadorsomedial
region

LHAjp

lateral hypothalamic area middle group medial tier juxtaparaventricular
region

LHAjvd

lateral hypothalamic area middle group medial tier juxtaventromedial
region dorsal zone

LHAjvv

lateral hypothalamic area middle group medial tier juxtaventromedial
region ventral zone

LHAma

lateral hypothalamic area middle group lateral tier ventral region
magnocellular nucleus
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LHApc

lateral hypothalamic area middle group lateral tier ventral region
parvicellular region

LHAs

lateral hypothalamic area middle group perifornical tier suprafornical
region

LHAsfa

lateral hypothalamic area middle group perifornical tier subfornical
region anterior zone

LHAsfp

lateral hypothalamic area middle group perifornical tier subfornical
region posterior zone

LHAvl

lateral hypothalamic area middle group lateral tier ventral region lateral
zone

LHAvm

lateral hypothalamic area middle group lateral tier ventral region medial
zone

PH

posterior hypothalamic nucleus

PVa

periventricular hypothalamic nucleus anterior part

PVH

paraventricular hypothalamic nucleus

PVHdp

paraventricular hypothalamic nucleus descending division dorsal
parvicellular part

PVHf

paraventricular hypothalamic nucleus descending division forniceal part

PVHlp

paraventricular hypothalamic nucleus descending division lateral
parvicellular part

PVHmpd

paraventricular hypothalamic nucleus parvicellular division medial
parvicellular part dorsal zone

PVHmpdl paraventricular hypothalamic nucleus parvicellular division medial
parvicellular part dorsal zone lateral wing
PVHmpv

paraventricular hypothalamic nucleus descending division medial
parvicellular part ventral zone

PVHpml

paraventricular hypothalamic nucleus magnocellular division posterior
magnocellular part lateral zone

PVHpmm paraventricular hypothalamic nucleus magnocellular division posterior
magnocellular part medial zone
PVHpv

paraventricular
hypothalamic
periventricular part

PVi

periventricular hypothalamic nucleus anterior part intermediate zone
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nucleus

parvicellular

division

RCH

lateral hypothalamic area anterior group retrochiasmatic area

SBPV

subparaventricular zone

SOp

supraoptic nucleus principal part

SOr

supraoptic nucleus retrochiasmatic part

TUi

lateral hypothalamic area middle group lateral tier tuberal nucleus
intermediate part

TUl

lateral hypothalamic area middle group lateral tier tuberal nucleus lateral
part

TUsv

lateral hypothalamic area middle group lateral tier tuberal nucleus
subventromedial part

TUte

lateral hypothalamic area middle group lateral tier tuberal nucleus terete
part

VMH

ventromedial hypothalamic nucleus

VMHa

ventromedial hypothalamic nucleus anterior part

VMHc

ventromedial hypothalamic nucleus central part

VMHdm

ventromedial hypothalamic nucleus dorsomedial part

VMHvl

ventromedial hypothalamic nucleus ventrolateral part

ZI

zona incerta

ZIda

zona incerta dopaminergic group
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